1. |
Glucosamine in osteoarthritis - increasing evidence? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 2-2
&NA;,
Preview
|
PDF (835KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
2. |
Should raised homocysteine levels be treated in vascular disease? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 3-3
&NA;,
Preview
|
PDF (691KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 4-4
&NA;,
Preview
|
PDF (710KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
4. |
Forgotten economic implications of Alzheimer's disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 5-6
Wayne Elwood,
Preview
|
PDF (1572KB)
|
|
摘要:
Alzheimer's disease (AD) is a progressive degenerative disease that requires specialised chronic care. It is the most common cause of dementia in the elderly and one of the most expensive diseases in the Western world (behind cardiovascular diseases and cancer). At present, AD accounts for an estimated $US100 billion/year in healthcare costs in the US. With the proportion of elderly patients in the population increasing, these healthcare costs are set to escalate. However, current economic analyses of AD are largely expeditions into uncharted territory, delegates were told at a Bayer-sponsored symposium at the 10th Annual Meeting of the Academy of Managed Care Pharmacy [Philadelphia, US; May 1998]. The economics of AD is complicated because the disease imposes enormous economic and emotional burdens on patients, their families and healthcare providers. Consequently, it is very difficult to accurately assess the impact of drug therapy in this disease.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
5. |
No evidence of a difference in statin effectiveness, says CCOHTA |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 6-6
&NA;,
Preview
|
PDF (762KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 7-7
&NA;,
Preview
|
PDF (722KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 8-8
&NA;,
Preview
|
PDF (722KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
8. |
COPD comes in from the cold with pharmaceutical companies |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 9-10
Wayne Elwood,
Preview
|
PDF (1504KB)
|
|
摘要:
At present, there are no strategies (other than smoking cessation) that prevent the progression of chronic obstructive pulmonary disease (COPD). Pharmaceutical companies are beginning to focus considerable research efforts into this area because of the poor prognosis for the large number of patients affected by COPD, the current lack of effective pharmacological agents and the significant economic burdens the disease imposes on healthcare systems and society. Several presentations focused on new approaches to treating COPD at the 1998 International Conference of the American Lung Association and the American Thoracic Society [Chicago, US; April 1998].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 10-10
&NA;,
Preview
|
PDF (752KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
10. |
&agr;-Glucosidase inhibitorsmutation-proof antiviral agents? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1142,
1998,
Page 11-11
&NA;,
Preview
|
PDF (732KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|